Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Research and Markets: Next Generation Sequencing (NGS) Report 2013: How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/10/2013 | 04:30pm CEST

Research and Markets (http://www.researchandmarkets.com/research/ddm37b/next_generation) has announced the addition of the "Next Generation Sequencing Report 2013" report to their offering.

The Next Generation Sequencing market is poised to reach $4.4B in 2018!

How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

NGS technologies drive the way toward personalized medicine

Our analysis provides 2013-2018 market data, along with player market shares at both equipment and consumable levels. Moreover, positioning strategy of each supplier has been analyzed in the document.

Discover the NGS market's complex organization, splitted in four segments

The market segmentation is a tool used to provide a vision of the market. Based on technical and economic criteria, fours segments have been identified: research, forensics, diagnostics and consumer.

Until recently, uses of Next Generation Sequencing tools were limited to research (human whole genome, exome, small genome, targeted, transcriptome, RNA profiling, chIP-Seq, metagenomics).

Nowadays, NGS technologies have found applications mainly in two fields: clinical diagnostics and forensics.

Our investigation describes both current and future applications.

Next Generation Sequencing technologies overview

  • In April 2003, human genome project was declared complete. This first human genome sequencing took 13 years, mobilized 20000 researchers and cost $3B!
  • Since the early 2000s, sequencing technologies have come a long way from Sanger sequencing (also called 1st generation sequencing) used for the human genome project to the Next Generation Sequencing technologies available today.
  • By sequencing a large number of DNA molecules in parallel after PCR amplification, technology developers have been able to sharply increase machine throughput by a factor of 10, along with a steep price reduction.
  • The launch of a new detection method based on electrochemical detections was also a huge step forward for the sequencing world.
  • Today, based on these new technologies, we can sequence the whole human genome in less than three hours with one laboratory technician and a total cost around $1000.
  • Technologies under development are poised to extend the boundaries with a targeted sequencing cost of $100.
  • All technologies currently in use and those under development are presented in our report. Benchmarking is also presented for eight different sequencing applications.

New opportunities arise for cartridge makers

  • The wide adoption of NGS technology has changed the way NGS suppliers are generating revenue. A shift occurred in the sales mix, moving from instruments to consumables which have a higher gross margin than instruments.
  • This leads to an increase in revenue based on consumable sales.
  • The number of NGS Platforms used worldwide will exploded in the next several years and the run time will continue to decrease. Therefore, the market of NGS consumables will follow.

Report's key features

- 2013-2018 Next Generation Sequencing equipment market

- 2013-2018 Next Generation Sequencing consumable market

- Market segmentation which highlights current and future applications

- Overview of sequencing technologies and cartridges associated

- Detailed supply chain and business model analysis highlighting the major changes expected over next few years

- Company profiles of the main players

Report objectives

- Provide an overview of global NGS market both at equipment and consumable levels.

- Present main players and technologies involved

- Analyze both technical and market trends

- Focus on microfluidic consumable cartridges used for genome testing

- Supply Chain analysis

Key Topics Covered:

1. Executive summary

2. Introduction

3. Market data

4. Market segmentation

5. Next Generation Sequencing technologies overview

6. Value chain and supply chain

7. Market trends and challenges

8. Company profiles

Companies Mentioned

- 23andme

- Affymetrix

- Azco Biotech Inc

- Baseclear

- Base 4

- BGI-Shenzhen

- Completegenomics

- DNAvision

- Genia Technologies

- Genapsys

- GnuBIO

- Hitachi

- Illumina

- LaserGen

- NabSys

- Noblegen Biosciences

- Oxford Nanopore Technologies

- Pacific Biosciences

- Qiagen

- Roche 454

- Stratos Genomics Inc.

- Thermo Fisher Scientific

- TSMC

For more information visit http://www.researchandmarkets.com/research/ddm37b/next_generation

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
07:22a EASYJET : *ubs cuts easyjet price target to 1,070 (1,150) pence - 'neutral'
07:22a MELROSE INDUSTRIES : *ubs raises melrose industries to 'buy' ('neutral') - target 200 (73) pence
07:21aDJASIA MARKETS : Asian Shares Turn Mostly Higher In Wake Of U.S. Presidential Debate
07:21aDJASIA MARKETS : Asian Shares Turn Mostly Higher In Wake Of U.S. Presidential Debate
07:20a WHL : WOOLWORTHS HOLDINGS LIMITED - Appointment of Scott Fyfe as CEO of Country Road Group ("CRG")
07:20a IAEA GC : Japanese Representative Emphasizes Promotion of MOX Fuel Use
07:20a THORNEY OPPORTUNITIES : Chairman's update September 2016
07:20a ADDRESS AIR POLLUTION AND ITS GROWING DISEASE BURDEN AS A PRIORITY : Who
07:20a VIRGIN MONEY UK : *goldman raises virgin money price target to 350 (280) pence - 'neutral'
07:19a ST JAMES PLACE : *goldman raises st james's place price target to 1,060 (1,040) pence - 'buy'
Latest news
Advertisement
Hot News 
0.24%Asian Shares Down on Europe Financial Health Concerns
-0.11%EUR/GBP TECHNICAL ANALYSIS : Double Top May Be Taking Shape
-0.15%Gold Prices Await Fed Guidance, Crude Oil Eyes OPEC Meeting
Most Read News
09/26 Disney, Microsoft among possible Twitter suitors
09/26 WELLS FARGO : U.S. Labor Department launches review of all Wells Fargo complaints
09/26 VERIZON COMMUNICATIONS : U.S. senator seeks SEC probe of Yahoo disclosure on hacking
09/26 AmEx can bar merchants from steering card customers elsewhere
09/26 UPRISING ACTIVISTS : Charlotte mayor, police chief should resign
Most recommended articles
09/26Predicting the U.S. Elections With The WMA Trump/Clinton Barometer
01:15aDJSIEMENS : U.S. Firms Turn to German Training Model to Fill Jobs Gap
12:45a ARENA REIT (ASX : ARF) talks FY16 results and outlook
12:29a LOTTE CHEMICAL : South Korean court to hear arrest request for Lotte chairman on September 28
12:20aDJOil Prices Lower on Iran Comments, U.S. Crude Stocks Growth